Vol. 23 No. 2 (2016), Letter to the Editor
Vol. 23 No. 2 (2016)

Capsaicina 8 % parche frente a pregabalina oral en paciente con dolor neuropático periférico

Letter to the Editor
Published 2016-03-01
Antonio Alcántara Montero
Hospital Don Benito-Villanueva de la Serena
A. González Curado
Hospital Don Benito-Villanueva de la Serena
PDF (Spanish)

Keywords

Carta al Director

Abstract

Se define el dolor neuropático (DN) como el dolor que aparece como consecuencia directa de una lesión o enfermedad del sistema somatosensorial.
PDF (Spanish)

References

1- Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008; 70:1630-5. 2- Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7:281-9. 3- Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. J Pain. 2008;136:380-7. 4- Jensen TS, Madsen CS, Finnerup NB. Pharmacology and treatment of neuropathic pains. Curr Opin Neurol. 2009;22:467-74. 5- O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009;122:S22-32.

Downloads

Download data is not yet available.